Regarding the data for FY2019 marked with ★, we have received independent assurance in our CSR Report 2020 (PDF version) so as to bolster the reliability of the information.
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
Corporate Governance Structure | Board structure |
Directors (Total) | Non-consolidated | Persons | 7 | 7 | 8 | 8 |
Independent outside directors | Non-consolidated | Persons | 2 | 2 | 3 | 3 | ||
Female directors | Non-consolidated | Persons | 0 | 0 | 0 | 0 | ||
Board of Auditors structure | Auditors (Total) | Non-consolidated | Persons | 4 | 4 | 4 | 4 | |
Independent outside auditors | Non-consolidated | Persons | 2 | 2 | 2 | 2 | ||
Female auditors | Non-consolidated | Persons | 1 | 1 | 1 | 1 | ||
Director Remuneration | Total | Non-consolidated | Million yen |
345 | 336 | 360 | 368 | |
President, Representative Director, and Chief Executive Officer | Non-consolidated | Million yen |
- | - | 114 | 116 | ||
Auditor Remuneration | Total | Non-consolidated | Million yen |
71 | 76 | 77 | 78 | |
Number of Board of Directors meetings | Non-consolidated | Times | 15 | 13 | 13 | 13 | ||
Number of Board of Auditors meetings | Non-consolidated | Times | 13 | 13 | 14 | 14 | ||
Board attendance rate(directors) | Non-consolidated | % | - | 100.0 | 100.0 | 100.0 | ||
Board attendance rate(auditors) | Non-consolidated | % | - | - | 100.0 | 92.3*1 | ||
Compliance | Number of bribery cases | Non-consolidated | Cases | 0 | 0 | 0 | 0 | |
Number of disciplinary actions | Non-consolidated | Cases | - | - | 5 | 9 | ||
Number of facilitation payments | Non-consolidated | Cases | 0 | 0 | 0 | 0 | ||
Compliance training attendance rate | Non-consolidated | % | - | - | 100 | 100 | ||
Number of reports | Non-consolidated | Cases | - | - | 44 | 68 | ||
Number of compliance violations | Non-consolidated | Cases | - | - | 5 | 9 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Research Development | R&D expenses | Non-consolidated | Million yen |
57,506 | 68,821 | 70,008 | 66,497 |
Ratio of R&D expenses to net sales | Non-consolidated | % | 23.5 | 26.3 | 24.3 | 22.7 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
Provision of Growth Opportunities | Company-wide joint training implementation status |
Workshop for deep understanding our mission statement | Non-consolidated | Participants × hours |
- | 943 | 317 | 317 |
Non-consolidated | Participants | - | 145 | 56 | 54 | |||
On-site training at medical institutions | Non-consolidated | Participants × hours |
- | - | - | 822 | ||
Non-consolidated | Participants | - | - | - | 105 | |||
Patient associations’ lecture meetings/Virtual Reality (VR) patient experience | Non-consolidated | Participants × hours |
- | - | - | 2,743 | ||
Non-consolidated | Participants | - | - | - | 1,704 | |||
Special training program for global business | Non-consolidated | Participants × hours |
1,388 | 2,704 | 3,341 | 3,634 | ||
Non-consolidated | Participants | 30 | 39 | 52 | 61 | |||
Speaking skill of English training program | Non-consolidated | Participants × hours |
- | 11,988 | 19,215 | 15,912 | ||
Non-consolidated | Participants | - | 111 | 260 | 216 | |||
Orientation for newly hired employees/ Follow-up training for newly hired employees |
Non-consolidated | Participants × hours |
- | 9,408 | 7,682 | 6,253 | ||
Non-consolidated | Participants | - | 98 | 86 | 70 | |||
Third-year employee training/ Fifth-year employee training |
Non-consolidated | Participants × hours |
- | 3,040 | 1,667 | 2,148 | ||
Non-consolidated | Participants | - | 190 | 164 | 173 | |||
Training for individual contributors promoted to the highest level/ Training for new core employees/ Training for new managers/ Manager training |
Non-consolidated | Participants × hours |
- | 11,968 | 11,653 | 4,400 | ||
Non-consolidated | Participants | - | 748 | 1,027 | 357 | |||
Self-development learning (Correspondence courses/Online foreign language conversation/ support for qualification tests) | Non-consolidated | Participants | 223 | 324 | 378 | 532 | ||
Elective and Voluntary training | Non-consolidated | Participants × hours |
- | 2,604 | 2,513 | 5,963 | ||
Non-consolidated | Participants | - | 217 | 231 | 681 | |||
Diversity management training | Non-consolidated | Participants × hours |
- | 108 | 1,529 | 32 | ||
Non-consolidated | Participants | - | 27 | 734 | 48 | |||
Career planning training | Non-consolidated | Participants × hours |
- | 1,362 | 426 | 345 | ||
Non-consolidated | Participants | - | 190 | 142 | 115 | |||
Coaching training | Non-consolidated | Participants × hours |
- | 1,950 | 992 | 858 | ||
Non-consolidated | Participants | - | 78 | 37 | 32 | |||
Annual training hours per employee | Non-consolidated | Hours | - | - | 35.5 | 30.7 | ||
Promoting active participation of persons with disabilities/mid-career employment | Employment of persons with disabilities | Non-consolidated | % | 2.30 | 2.24 | 2.28 | 2.20 | |
Mid-career employment(Cumulative) | Non-consolidated | Persons | 322 | 380 | 440 | 446 | ||
Employee composition | Male ratio of new graduates | Non-consolidated | % | 57 | 66 | 51 | 66 | |
Female ratio of new graduates | Non-consolidated | % | 43 | 34 | 49 | 34 | ||
Employee(Male) | Non-consolidated | Persons | 2,358 | 2,629 | 2,682 | 2,676 | ||
Employee(Female) | Non-consolidated | Persons | 524 | 570 | 602 | 611 | ||
Employee(total) | Non-consolidated | Persons | 3,062 | 3,199 | 3,284 | 3,287 | ||
Contract workers ratio | Non-consolidated | % | - | 0.3 | 0.1 | 0.1 | ||
Temporary staff ratio | Non-consolidated | % | - | 8.8 | 8.9 | 8.0 | ||
Average age (male) | Non-consolidated | Years old | 41.1 | 42.1 | 42.6 | 42.7 | ||
Average age (female) | Non-consolidated | Years old | 37.1 | 37.9 | 38.0 | 37.9 | ||
Average age (total) | Non-consolidated | Years old | 40.4 | 41.4 | 41.8 | 41.9 | ||
Average consecutive years of employment(male) | Non-consolidated | Years | 15.9 | 16.0 | 16.3 | 15.9 | ||
Average consecutive years of employment(female) | Non-consolidated | Years | 12.3 | 11.8 | 12.0 | 11.1 | ||
Average consecutive years of employment(total) | Non-consolidated | Years | 15.3 | 15.3 | 15.5 | 15.0 | ||
Employee information | Average annual salary | Non-consolidated | JPY 10,000 | 897 | 906 | 917 | 928 | |
Collective bargaining rights holding rate | Non-consolidated | % | - | - | - | 97.3 | ||
Labor union participation rate | Non-consolidated | % | 68.6 | 66.8 | 65.1 | 60.8 | ||
Employee satisfaction rate (male) | Non-consolidated | % | - | - | 68 | - | ||
Employee satisfaction rate (female) | Non-consolidated | % | - | - | 57 | - | ||
Employee satisfaction rate (all) | Non-consolidated | % | 62 | - | 66 | - | ||
Female manager rate | Non-consolidated | % | 3.4 | 3.9 | 4.0 | 4.6 | ||
Turnover and retention rate | Retention rate after 3 years(male) | Non-consolidated | % | 93.1 | 98.4 | 96.1 | 95.4 | |
Retention rate after 3 years(female) | Non-consolidated | % | 85.4 | 96.9 | 100.0 | 90.9 | ||
Retention rate after 3 years(total) | Non-consolidated | % | 89.9 | 97.8 | 97.8 | 93.9 | ||
Full-time employee turnover rate(voluntary resignation) | Non-consolidated | % | 1.0 | 1.3 | 1.5 | 1.6 | ||
Full-time employee turnover rate(Mandatory retirement, etc.) | Non-consolidated | % | 0.9 | 0.7 | 0.6 | 0.2 | ||
Full-time employee turnover rate(total) | Non-consolidated | % | 1.9 | 2.0 | 2.1 | 1.8 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
Enhancing cultivation of employee-friendly workplaces | Overtime hours | Non-consolidated | % compared to previous year |
N/A | ▽0.5% | ▽5.7%(compared to FY2014) | ▽14.5%(compared to FY2014) | |
Percentage of paid vacation taken | Non-consolidated | % compared to previous year |
N/A | △6.4% | △17.2%(compared to FY2014) | △24.7%(compared to FY2014) | ||
Occupational injuries |
Number of lost-time injuries ★ |
All Japanese operation sites (Employees)*2 |
Incidents | 1 | 1 | 1 | 0 | |
All Japanese operation sites (Temporary employees)*6 |
Incidents | - | - | - | 1 | |||
Lost-time injury frequency rate*3★ | All Japanese operation sites (Employees)*2 |
- | 0.16 | 0.16 | 0.15 | 0.00 | ||
All Japanese operation sites (Temporary employees)*6 |
- | - | - | - | 2.09 | |||
Number of occupational illnesses*4★ | All Japanese operation sites (Employees)*6 |
Incidents | - | - | - | 0 | ||
Occupational illness frequency rate*5★ | All Japanese operation sites (Employees)*6 |
- | - | - | - | 0.00 | ||
Supporting disease prevention, early detection and early treatment | Medical checkups received | Non-consolidated | % | - | 99.1 | 99.4 | 99.7 | |
Cancer screening rate | Stomach cancer screening | Non-consolidated | % | - | 97.2 | 97.3 | 97.7 | |
Lung cancer screening | Non-consolidated | % | - | 99.3 | 99.7 | 99.9 | ||
Colorectal cancer screening | Non-consolidated | % | - | 93.9 | 93.6 | 95.8 | ||
Breast cancer screening | Non-consolidated | % | - | 90.0 | 88.3 | 86.7 | ||
Cervical cancer | Non-consolidated | % | - | 43.4 | 42.3 | 47.3 | ||
Mental health | Stress checks received | Non-consolidated | % | - | 95.1 | 99.4 | 99.8 | |
Health promotion | Number of participants in walking campaign | Employees | Non-consolidated | Persons | 887 | 1,088 | 1,169 | 1,450 |
Family | Non-consolidated | Persons | 256 | 472 | 771 | 987 | ||
Temporary staff, etc. | Non-consolidated | Persons | 68 | 99 | 90 | 124 | ||
Walking campaign total employee participation rate | Non-consolidated | % | - | 34 | 35 | 44 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | ||
---|---|---|---|---|---|---|---|---|---|
GHG emissions | Energy-derived GHG emissions(Location-basis)★ | Production and research sites | 10,000 t-CO2 |
2.06 | 2.07 | 2.17 | 2.37 | ||
Headquarters and other Sites in Japan(including tenant locations) | 10,000 t-CO2 |
0.17 | 0.17 | 0.18 | 0.17 | ||||
Total | 10,000 t-CO2 |
2.23 | 2.24 | 2.35 | 2.54 | ||||
Energy- derived GHG emissions scope breakdown (Location- basis)★ |
Scope 1 | All operation sites | 10,000 t-CO2 |
0.85 | 0.85 | 0.90 | 0.97 | ||
Scope 2 | All operation sites | 10,000 t-CO2 |
1.38 | 1.39 | 1.45 | 1.57 | |||
GHG emissions (Market-basis)★ | Production and research sites | 10,000 t-CO2 |
2.73 | 2.72 | 2.61 | 2.52 | |||
Headquarters and other Sites in Japan(including tenant locations) | 10,000 t-CO2 |
0.26 | 0.26 | 0.24 | 0.21 | ||||
Total | 10,000 t-CO2 |
2.99 | 2.98 | 2.85 | 2.73 | ||||
GHG emissions scope breakdown (Market- basis)★ |
Scope 1 | All operation sites | 10,000 t-CO2 |
0.85 | 0.87 | 0.95 | 1.02 | ||
Scope 2 | All operation sites | 10,000 t-CO2 |
2.14 | 2.11 | 1.90 | 1.71 | |||
GHG emissions in the value chain (Scope3)★ | Cat1 | Purchased goods and services*7 | All operation sites | 10,000 t-CO2 |
9.71 | 0.85 | 0.81 | -*8 | |
Cat2 | Capital goods | 10,000 t-CO2 |
2.70 | 5.26 | 6.04 | 2.69 | |||
Cat3 | Fuel- and energy-related activities not included in scope 1 or scope 2 | 10,000 t-CO2 |
0.15 | 0.15 | 0.15 | 0.28 | |||
Cat4 | Upstream transportation and distribution | 10,000 t-CO2 |
0.01 | 0.01 | 0.01 | 0.01 | |||
Cat5 | Waste generated in operations | 10,000 t-CO2 |
0.03 | 0.03 | 0.03 | 0.03 | |||
Cat6 | Business travel | 10,000 t-CO2 |
0.22 | 0.25 | 0.23 | 0.40 | |||
Cat7 | Employee commuting | 10,000 t-CO2 |
0.03 | 0.04 | 0.04 | 0.05 | |||
Cat8 | Upstream leased assets | 10,000 t-CO2 |
0.35 | 0.35 | 0.33 | 0.29 | |||
Cat9 | Downstream transportation and distribution | 10,000 t-CO2 |
0.62 | 0.53 | 0.53 | -*8 | |||
Cat10 | Processing of sold products | 10,000 t-CO2 |
Not relevant | Not relevant | Not relevant | Not relevant | |||
Cat11 | Use of sold products | 10,000 t-CO2 |
Not relevant | Not relevant | Not relevant | Not relevant | |||
Cat12 | End-of-life treatment of sold products | 10,000 t-CO2 |
0.02 | 0.01 | 0.02 | 0.02 | |||
Cat13 | Downstream leased assets | 10,000 t-CO2 |
0.03 | 0.03 | 0.03 | 0.03 | |||
Cat14 | Franchises | 10,000 t-CO2 |
Not relevant | Not relevant | Not relevant | Not relevant | |||
Cat15 | Investments | 10,000 t-CO2 |
Not relevant | Not relevant | Not relevant | Not relevant | |||
Total | 10,000 t-CO2 |
13.87 | 7.51 | 8.22 | -*8 | ||||
Energy consumption | Energy consumption★ | Production and research sites | 10,000 GJ |
52.72 | 52.65 | 55.42 | 60.80 | ||
Headquarters and other Japan offices/sites(including tenant locations) | 10,000 GJ |
5.04 | 5.09 | 5.13 | 4.95 | ||||
Total | 10,000 GJ |
57.76 | 57.74 | 60.55 | 65.75 | ||||
Renewable energy amount |
Solar power generation (by private power generation) |
All operation sites | MWh | 53.96 | 55.29 | 64.97 | 63.03 | ||
Solar power generation (by purchase) |
MWh | - | - | - | 2,427 | ||||
hydroelectric generation | MWh | - | - | - | 1,278 | ||||
Biomass power generation (by purchase) | MWh | - | - | 2,900 | 2,460.90 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
Water intake★ | Water intake per site | (Basin) | Fujiyama Plant/Joto factory (current Joto Pharmaceutical Product Development Center)/MinaseResearch Institute/Fukui Research Institute/Tsukuba Research Institute/Headquarters, other Japan offices and sites | 10,000 m3 |
29.84 | 32.56 | 34.80 | 29.67 |
Fuji river | Fujiyama Plant | 10,000 m3 |
19.57 | 20.56 | 24.02 | 18.50 | ||
Yodo river | Joto factory (current Joto Pharmaceutical Product Development Center) | 10,000 m3 |
0.72 | 0.55 | 0.60 | 0.51 | ||
Yodo river | Minase Research Institute | 10,000 m3 |
4.52 | 5.13 | 4.12 | 3.91 | ||
Kuzuryu river | Fukui Research Institute | 10,000 m3 |
3.94 | 3.87 | 3.13 | 2.73 | ||
Lake Kasumigaura | Tsukuba Research Institute | 10,000 m3 |
1.09 | 0.81 | 0.60 | 0.71 | ||
Fushino river | Yamaguchi Plant | 10,000 m3 |
- | - | 0.82 | 1.81 | ||
Basins of major offices*9 | Headquarters and other Japan offices/sites (including some tenant locations) | 10,000 m3 |
- | 1.64 | 1.51 | 1.50 | ||
Wastewater★ | Wastewater site | (destination) | Fujiyama Plant/Joto factory (current Joto Pharmaceutical Product Development Center)/MinaseResearch Institute/Fukui Research Institute/Tsukuba Research Institute/Headquarters, other Japan offices and sites | 10,000 m3 |
19.97 | 23.51 | 25.99 | 23.52 |
River | Fujiyama Plant | 10,000 m3 |
12.89 | 14.86 | 17.84 | 14.51 | ||
Sewer | Joto factory (current Joto Pharmaceutical Product Development Center) | 10,000 m3 |
0.72 | 0.55 | 0.60 | 0.51 | ||
Sewer | Minase Research Institute | 10,000 m3 |
4.52 | 5.13 | 4.12 | 3.91 | ||
Sewer | Fukui Research Institute | 10,000 m3 |
0.75 | 0.52 | 0.50 | 0.57 | ||
Sewer | Tsukuba Research Institute | 10,000 m3 |
1.09 | 0.81 | 0.60 | 0.71 | ||
River | Yamaguchi Plant | 10,000 m3 |
- | - | 0.82 | 1.81 | ||
Sewer | Headquarters and other Japan offices/sites (including some tenant locations) | 10,000 m3 |
- | 1.64 | 1.51 | 1.50 | ||
Percentage of reused water | Production and research sites | % | - | 5.90 | 4.60 | 5.51 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
Waste | Industrial waste★ |
Waste generated | Production and research sites | t | 534.6 | 719.1 | 446.4 | 430.8 |
Specially management industrial waste | Production and research sites | t | 138.1 | 137.0 | 145.6 | 161.9 | ||
final landfill disposal | Production and research sites | t | 0.7 | 7.4 | 0.4 | 0.2 | ||
final landfill disposal rate | Production and research sites | % | 0.13 | 1.02 | 0.09 | 0.05 | ||
final landfill disposal (Non-industrial waste is included) |
Production and research sites | t | 10.66 | 18.04 | 9.35 | 6.75 | ||
Container and packaging usage | Plastic | Production and research sites | t | - | 164.7 | 171.7 | 162.8 | |
Paper | Production and research sites | t | - | 192.0 | 202.7 | 200.9 | ||
Glass (colorless) | Production and research sites | t | - | 0 | 0 | 0 | ||
Glass (brown) | Production and research sites | t | - | 0.3 | 0.3 | 0.3 | ||
Obligatory recycling amount | Plastic | Production and research sites | t | - | 34.7 | 35.5 | 31.2 | |
Paper | Production and research sites | t | - | 1.6 | 1.6 | 1.5 | ||
Glass (colorless) | Production and research sites | t | - | 0 | 0 | 0 | ||
Glass (brown) | Production and research sites | t | - | 0 | 0 | 0 | ||
Commissioning fee paid for recycling | Production and research sites | 1,000 yen |
- | 1,723 | 1,650 | 1,546 | ||
PRTR substance | Production and research sites | t | 10.94 | 11.79 | 9.76 | 11.34 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Emissions into the air | SOx | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 |
NOx | Production and research sites | t | 13.80 | 7.812 | 8.38 | 8.10 | |
Particulate matter | Production and research sites | t | 0.42 | 0.34 | 0.28 | 0.33 | |
PRTR substance | Production and research sites | t | 0.20 | 0.36 | 0.25 | 0.15 | |
Emissions into water | Wastewater | Production and research sites | 10,000 m3 |
19.97 | 21.87 | 24.48 | 22.02 |
BOD | Production and research sites | t | 2.38 | 2.22 | 1.27 | 1.31 | |
PRTR substance | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 | |
---|---|---|---|---|---|---|---|---|
PRTR substances | Amount handled by the notified facilities |
Acetonitrile | Production and research sites | t | 8.29 | 8.98 | 7.19 | 8.51 |
Normal-hexane | Production and research sites | t | 2.95 | 2.97 | 2.82 | 2.98 | ||
Total | Production and research sites | t | 11.24 | 11.95 | 10.01 | 11.49 | ||
Dioxins | Production and research sites | mg-TEQ | - | - | - | - | ||
Notified release(into the air) | Acetonitrile | Production and research sites | t | 0.20 | 0.36 | 0.25 | 0.15 | |
Normal-hexane | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | ||
Total | Production and research sites | t | 0.20 | 0.36 | 0.25 | 0.15 | ||
Dioxins | Production and research sites | mg-TEQ | 0.27 | 0.00 | - | - | ||
Notified release(into public waters) | Acetonitrile | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | |
Normal-hexane | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | ||
Total | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | ||
Dioxins | Production and research sites | mg-TEQ | 0.00 | 0.00 | 0.00 | 0.00 | ||
Notified transfer(contained in waste) | Acetonitrile | Production and research sites | t | 8.09 | 8.82 | 6.94 | 8.36 | |
Normal-hexane | Production and research sites | t | 2.85 | 2.97 | 2.82 | 2.98 | ||
Total | Production and research sites | t | 10.94 | 11.79 | 9.76 | 11.34 | ||
Dioxins | Production and research sites | mg-TEQ | 16.75 | 0.00 | - | - | ||
Notified transfer(Into public sewage) | Acetonitrile | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | |
Normal-hexane | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | ||
Total | Production and research sites | t | 0.00 | 0.00 | 0.00 | 0.00 | ||
Dioxins | Production and research sites | mg-TEQ | 0.00 | 0.00 | - | - | ||
Notified release and transfer (total) | Acetonitrile | Production and research sites | t | 8.29 | 8.98 | 7.19 | 8.51 | |
Normal-hexane | Production and research sites | t | 2.95 | 2.97 | 2.82 | 2.98 | ||
Total | Production and research sites | t | 11.24 | 11.95 | 10.01 | 11.49 | ||
Dioxins | Production and research sites | mg-TEQ | 17.02 | 0.00 | - | - | ||
PCB | Joto factory (current Joto Pharmaceutical Product Development Center) | Stored(Fluorescent lamp) | Production and research sites | Stand | 552 | 552 | 552 | 0 |
Disposed | Production and research sites | Stand | 6 | 6 | 6 | 558 | ||
Minase Research Institute | Disposed | Production and research sites | Stand | 2 | 2 | 2 | 2 | |
CFC | calculated leakage of fluorocarbons★ | Production and research sites | t-CO2 | - | 197.9 | 494.4 | 443.56 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Green Purchasing | office supplies purchased | All operation sites | % | 83 | 80 | 76 | 76 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Management | Acquisition status of ISO14001 | Production site | site | 100% | 100% | 100% | 100% |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Environmental Violations | Violation cases (with fines of USD 10,000 or more) | All operation sites | Cases | 0 | 0 | 0 | 0 |
Category | Item | Scope | Unit | FY2016 | FY2017 | FY2018 | FY2019 |
---|---|---|---|---|---|---|---|
Initiatives for medical advancement | Osamu Hayaishi Memorial Award | - | Persons | - | 1 | 1 | 1 |
Recipients of theresearch grant | - | Persons | 12 | 12 | 12 | 12 | |
Recipients of theresearch scholarship grant(40 years old and below) | - | Persons | 16 | 16 | 16 | 16 | |
Recipients of the Osamu Hayaishi Memorial Scholarship for Study Abroad | - | Persons | 8 | 8 | 8 | 8 |